Loading…

Effects of morphine withdrawal on catecholaminergic neurons on heart right ventricle; implication of dopamine receptors

The purpose of our study was to examine the effects of D 1 -and D 2 -dopamine receptors blockade on the changes in the ventricular content of catecholamines in rats withdrawn from morphine. Rats were given morphine by subcutaneous (sc) implantation of morphine pellets for 5 days. On the eighth day,...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of physiology and pharmacology 2001-10, Vol.79 (10), p.885-891
Main Authors: Milanés, M V, Marín, M T, Laorden, M L
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of our study was to examine the effects of D 1 -and D 2 -dopamine receptors blockade on the changes in the ventricular content of catecholamines in rats withdrawn from morphine. Rats were given morphine by subcutaneous (sc) implantation of morphine pellets for 5 days. On the eighth day, morphine withdrawal was induced by sc administration of naloxone (1 mg/kg), and rats were killed 30 min later. Pretreatment with SCH 23390 (dopamine D 1 , D 5 receptor antagonist) 15 min prior to naloxone administration suppressed some the behavioural signs of morphine withdrawal, whereas eticlopride (dopamine D 2 , D 3 , D 4 receptor antagonist) did not. In addition, biochemical analysis indicate that SCH 23390 completely abolished the withdrawal-induced increase in noradrenaline and dopamine turnover in the right ventricle. By contrast, eticlopride did not block the hyperactivity of catecholaminergic neurons in the heart during morphine withdrawal. These data suggest that the hyperactivity of catecholaminergic neurons in the heart during morphine withdrawal is dependent upon D 1 dopamine receptor activation. In addition, our results exclude the involvement of D 2 dopamine receptors.Key words: morphine withdrawal, right ventricle, catecholaminergic activity.
ISSN:0008-4212
1205-7541
DOI:10.1139/y01-067